ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Insiders Cash Out as CEO Bets Big

By ORTEX News · Edited by , Editor, ORTEX News1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

The most eye-catching recent filing came from SMMT. Summit Therapeutics Chairman and CEO Robert Duggan filed a $50M purchase on June 12. That's 3.8 million shares at $13.12 each. It signals strong personal conviction from the man running the company.

Over at NCLH, Director Steve Pagliuca filed two back-to-back buys totalling nearly $25M. He picked up 1.38 million shares in early June at around $18. That's a notable bet on the cruise operator's recovery story.

On the sell side, NVDA Director Mark Stevens filed $186M in sales on June 23. The trades took place June 18 at around $210 per share. That's a large exit near all-time highs.

ASTS founder and CEO Abel Avellan filed a $146.7M sale on June 23. He sold 2.5 million shares at $58.68. AST SpaceMobile has more than doubled this year, making it a natural point to take profits.

BBY founder Richard Schulze filed two sales totalling over $32M this past week. He sold at roughly $78 per share. Best Buy shares have climbed this year and Schulze appears to be trimming his long-held position.

WMT saw the Walton Family Holdings Trust file $533M in combined sales on June 18. The trades occurred June 16 at around $121 per share — routine for a family office managing a massive position, but still notable in scale.

Stocks in this article

How this article was generated

Generated
29 Jun 2026, 16:12
Prompt version
v1.0
Data sources
Institutional positioning

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.